Radiotherapy for muscle-invasive carcinoma of the bladder: Results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 1, 2004, Pages 197-207

  Cowan, Richard A ^a   McBain, Catherine A ^a   Ryder, W David J ^a   Wylie, James P ^a   Logue, John P ^a   Turner, Sandra L ^b   Van Der Voet, Johannes ^c   Collins, Conor D ^d   Khoo, Vincent S ^a   Read, Graham R ^e  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b WESTMEAD HOSPITAL   (Australia)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^e ROYAL PRESTON HOSPITAL   (United Kingdom)

Author keywords

Bladder cancer; Dose; Partial bladder; Radiotherapy

Indexed keywords

CARCINOGENS; DOSIMETERS; MUSCLE; PATIENT MONITORING; POPULATION STATISTICS; RADIOTHERAPY; TOXICITY;

BLADDER; IRRADIATED VOLUME; LOCAL CONTROL; SURVIVAL RATE;

ONCOLOGY;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CONTROL; CANCER SURVIVAL; CONTROLLED STUDY; CYSTOSCOPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; REMISSION INDUCTION; SALVAGE THERAPY; URINARY BLADDER NEOPLASMS;

EID: 10044227869     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.10.018     Document Type: Article

References (23)

1. www.cancerresearchuk.org/about cancer/statistics.
2. Duncan W., Quilty P.M. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder treated by radical megavoltage X-ray therapy. Radiother Oncol. 7:1986;299-310.
3. Gospodarowicz M.K., Hawkins N.V., Rawlings G.A., et al. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder Failure analysis. J Urol. 142:1989;1448-1454.
4. Morrison R. The results of treatment of cancer of the bladder - A clinical contribution to radiobiology. Clin Radiol. 26:1975;67-75.
5. Maciejewski B., Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol. 21:1991;163-170.
6. Marks L.B., Carroll P.R., Dugan T.C., et al. The response of the urinary bladder, urethra and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 31:1995;1257-1280.
7. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21:1991;109-122.
8. Van der Werf-Messing B., Menon R.S., Hop W.C.J. Cancer of the urinary bladder category T2, T3 (NxM0) treated by interstitial radium implant Second report. Int J Radiat Oncol Biol Phys. 9:1983;481-485.
9. World Health Organisation. WHO handbook for reporting results of cancer treatment, vol 48. 1979;WHO, Geneva.
10. International Commission on Radiation Units and Measurements. Report 50 Prescribing, recording and reporting photon beam therapy. 1993;ICRU, Bethesda.
11. Steel G.G. Basic clinical radiobiology. 3rd ed. 2002;Arnold Publishers, London.
12. Coppin C.M., Gospodarowicz M.K., James K., et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol. 14:1996;2901-2907.
13. Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment Long-term outcomes of 190 patients with invasive bladder cancer. Urology. 60:2002;62-67.
14. Rodel C., Grabenhauer, Kuhn R., et al. Combined modality treatment and selective organ preservation in invasive bladder cancer: Long term results. J Clin Oncol. 20:2002;3061-3071.
15. Shelly MD, Barber J, Wilt T, et al. Surgery versus radiotherapy for muscle invasive bladder cancer (Cochrane review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software; 2002.
16. Quilty P.M., Duncan W., Kerr G.R. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer. Clin Radiol. 36:1985;615-618.
17. Mazeron J., Crook J., Chopin D., et al. Conservative treatment of bladder carcinoma by partial cystectomy and interstitial iridium 192. Int J Radiat Oncol Biol Phys. 15:1988;1323-1330.
18. Turner S.L., Swindell R., Bowl N., et al. Bladder movement during radiation therapy for bladder cancer Implications for treatment planning. Int J Radiat Oncol Biol Phys. 39:1997;355-360.
19. Miralbell R., Nouet P., Rouzaud M., et al. Radiotherapy of bladder cancer Relevance of bladder volume changes in planning boost treatment. Int J Radiat Oncol Biol Phys. 41:1998;741-746.
20. Shirato H., Shimizu S., Kitamura K., et al. Four-dimensional treatment planning and fluoroscopic real-time tumour tracking radiotherapy for moving tumor. Int J Radiat Oncol Biol Phys. 48:2000;435-442.
21. Jaffray D.A., Drake D.G., Moreau M., et al. A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets. Int J Radiat Oncol Biol Phys. 45:1999;773-789.
22. Welsh J.S., Patel R.R., Ritter M.A., et al. Helical tomotherapy An innovative technology and approach to radiation therapy. Technol Cancer Res Treat. 1:2002;311-316.
23. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 2001;19:666-675.